AMGN (STOCKS)
Amgen Inc
$417.840000
+1.660000 (+0.40%)
Prev close: $416.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Robert A. Bradway
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $248,176.08M
- Employees
- 28,000
- P/E (TTM)
- 25.85
- P/B (TTM)
- 19.25
- Dividend Yield
- 235.48%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
15
Buy
19
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$6.29 | $5.73 | +0.5619 | +9.81% |
|
Mar 2026 (Q1)
|
$5.15 | $4.85 | +0.2978 | +6.14% |
|
Dec 2025 (Q4)
|
$5.29 | $4.83 | +0.4617 | +9.56% |
|
Sep 2025 (Q3)
|
$5.64 | $5.11 | +0.5256 | +10.28% |
Financial Statements
| Revenues | $38.10B |
| Benefits Costs and Expenses | $27.81B |
| Cost Of Revenue | $11.61B |
| Costs And Expenses | $26.67B |
| Gross Profit | $26.48B |
| Nonoperating Income/Loss | $1.53B |
| Operating Expenses | $15.06B |
| Selling, General, and Administrative Expenses | $7.02B |
| Depreciation and Amortization | $900.00M |
| Other Operating Expenses | $7.14B |
| Operating Income/Loss | $11.43B |
| Income/Loss From Continuing Operations After Tax | $8.74B |
| Income/Loss From Continuing Operations Before Tax | $10.29B |
| Income Tax Expense/Benefit | $1.54B |
| Net Income/Loss | $8.74B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $8.74B |
| Net Income/Loss Available To Common Stockholders, Basic | $8.74B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $16.22 |
| Diluted Earnings Per Share | $16.10 |
| Basic Average Shares | 1,078,000,000 |
| Diluted Average Shares | 1,086,000,000 |
| Assets | $95.64B |
| Current Assets | $34.96B |
| Inventory | $6.22B |
| Other Current Assets | $28.74B |
| Noncurrent Assets | $60.68B |
| Fixed Assets | $8.55B |
| Intangible Assets | $20.49B |
| Other Non-current Assets | $31.64B |
| Liabilities | $83.95B |
| Current Liabilities | $25.50B |
| Accounts Payable | $2.87B |
| Other Current Liabilities | $22.64B |
| Noncurrent Liabilities | $58.45B |
| Long-term Debt | $57.30B |
| Other Non-current Liabilities | $1.15B |
| Equity | $11.69B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.69B |
| Liabilities And Equity | $95.64B |
| Net Cash Flow From Operating Activities | $12.48B |
| Net Cash Flow From Operating Activities, Continuing | $12.48B |
| Net Cash Flow From Investing Activities | -$2.39B |
| Net Cash Flow From Investing Activities, Continuing | -$2.39B |
| Net Cash Flow From Financing Activities | -$4.13B |
| Net Cash Flow From Financing Activities, Continuing | -$4.13B |
| Net Cash Flow | $5.96B |
| Net Cash Flow, Continuing | $5.96B |
| Comprehensive Income/Loss | $9.17B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $9.17B |
| Other Comprehensive Income/Loss | $9.17B |
| Other Comprehensive Income/Loss Attributable To Parent | $425.00M |